Results 171 to 180 of about 1,146,644 (343)

Radiation doses [PDF]

Nature, 1990
openaire   +2 more sources

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain

Medical Cannabis and Cannabinoids, 2023
Sebastian Jugl, Amie J. Goodin, Joshua D. Brown   +2 more
doaj   +1 more source

Dose Pack Dosing Unit [PDF]

, 2020
openaire   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study [PDF]

, 2001
Luca Dal Prato
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia

Neuropsychiatric Disease and Treatment
Leslie Citrome,1 Christoph U Correll,2– 6 Andrew J Cutler,7,8 Martin Dunbar,9 Amber R Hoberg,10 Craig Hopkinson,9 Gregory W Mattingly,11,12 James A McGrory,9 Bhaskar Rege,9 Peter J Weiden,13 David McDonnell14 1New York Medical College, Valhalla, NY, USA;
Citrome L, Correll CU, Cutler AJ, Dunbar M, Hoberg AR, Hopkinson C, Mattingly GW, McGrory JA, Rege B, Weiden PJ, McDonnell D   +10 more
doaj  

Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit

Medical Cannabis and Cannabinoids, 2021
Sebastian Jugl, Ruba Sajdeya, Earl J. Morris, Amie J. Goodin, Joshua D. Brown   +4 more
doaj   +1 more source

Preliminary insights into artificial intelligence guided dosing in hypertension and diabetes: challenges and lessons learnt in a pilot feasibility study. [PDF]

JAMIA Open
Sumner J, Motani M, Mohamed Ali J, Lee SE, Ho D, Tan DHT, Ling LH, Tan ATH, Teng GG, Seetharaman SK, Gollamudi SPK, Chong LS, Ho D, Mukhopadhyay A.   +13 more
europepmc   +1 more source